Introduction
As the brain develops postnatally, particular regions undergo heightened periods of plasticity when their underlying neural circuits are sculpted by experiences to establish normal perceptual and cognitive behaviors such as sensory processing, language, and emotional processing. Conversely, absent or abnormal experiences, such as sensory or social deprivation, during this critical period can disrupt the establishment of behaviors [1] ( Figure 1A) . By understanding the fundamental neurobiology of how plasticity and recovery become limited as a function of age after abnormal experience or injury during a critical window, we will be able to develop better therapeutic approaches for developmental disorders and adult brain injuries [1] . However, translating the emerging evidence of critical windows of susceptibility from animal models to humans has been hindered by the lack of appropriate human biomarkers that capture the dynamic, time-dependent nature of molecular interactions during brain development. Here we propose novel tooth-matrix biomarkers not only for the identification of critical developmental periods of brain plasticity in humans but also for their potential clinical applications.
Molecular Mechanisms of Postnatal Critical Period for Brain Plasticity
One of the best-studied models of a critical period for brain plasticity is the enduring loss of visual responsiveness and anatomic remodeling in the primary visual cortex of an eye deprived of vision early in life, resulting in amblyopia [2] . The use of the visual system offers a unique opportunity to examine neuroplasticity from finescale molecular and cellular processes to entire systems across species including rodents, in which genetic manipulation can be used to dissect the molecular mechanisms. After extensive studies using rodent models, we now know that a natural critical period comprises a sequence of molecular events. The critical period is triggered by a drastic adjustment of the excitatory/inhibitory (E/I) balance facilitated by the emergence of molecular accelerators of plasticity that collectively contribute to the later maturation of periods. In addition to a prenatal critical period for placenta-mediated environmental influences (e.g., toxins that cross the placenta), there is a postnatal critical period for experience-dependent brain plasticity (gray background). (B) The expression of molecular accelerators and brakes that regulate brain plasticity shapes the critical period for brain plasticity. (C) We propose that the expression of known molecular accelerators and brakes that regulate brain plasticity can be mapped in teeth, revealing changes in their expression levels across developmental stages. Expected developmental expression patterns of plasticity regulators in teeth will correlate with those in the brain. (D) Clinical applications of tooth-matrix biomarkers. Measurement of molecular regulators of brain plasticity in teeth will allow us to determine: (i) individual temporal variability of the critical period; (ii) whether disruption of the critical period (e.g., via genetic or environmental factors that augment or restrict plasticity) is involved in the etiology of neurodevelopmental disorders such as schizophrenia in which the brakes are reduced; and (iii) whether personalized therapeutics based on individual molecular profiles could restore proper balance to brain plasticity regulators.
